NDC 68016-344

Cold Sore Fever Blister Treatment

Docosanol

Cold Sore Fever Blister Treatment is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Chain Drug Consortium, Llc. The primary component is Docosanol.

Product ID68016-344_bd59d4cb-c304-4561-b606-e7984412f975
NDC68016-344
Product TypeHuman Otc Drug
Proprietary NameCold Sore Fever Blister Treatment
Generic NameDocosanol
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2021-06-01
Marketing CategoryANDA /
Application NumberANDA208754
Labeler NameChain Drug Consortium, LLC
Substance NameDOCOSANOL
Active Ingredient Strength100 mg/g
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 68016-344-07

1 TUBE in 1 PACKAGE (68016-344-07) > 2 g in 1 TUBE
Marketing Start Date2021-06-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cold Sore Fever Blister Treatment" or generic name "Docosanol"

NDCBrand NameGeneric Name
0363-9220Cold Sore Fever Blister TreatmentDocosanol
0363-9222Cold Sore Fever Blister TreatmentDocosanol
11673-926Cold Sore Fever Blister TreatmentDocosanol
11822-0951Cold Sore Fever Blister TreatmentDocosanol
11822-3927Cold Sore Fever Blister TreatmentDocosanol
68016-344Cold Sore Fever Blister TreatmentDocosanol
0135-0200ABREVAdocosanol
50090-3476ABREVAdocosanol
30142-322Cold Sore Fever BlisterDocosanol
37808-229Cold Sore TreatmentDocosanol
0363-2981DocosanolDocosanol
0472-2981DocosanolDocosanol
0591-2981DocosanolDocosanol
21130-422DocosanolDocosanol
41163-722DocosanolDocosanol
41163-724DocosanolDocosanol
41250-932DocosanolDocosanol
46122-624DocosanolDocosanol
46122-681DocosanolDocosanol
49035-259DocosanolDocosanol
55301-922DocosanolDocosanol
55910-722DocosanolDocosanol
62011-0433DocosanolDocosanol
68016-052DocosanolDocosanol
70000-0517DocosanolDocosanol
72476-492DocosanolDocosanol
72476-922DocosanolDocosanol
79903-011DocosanolDocosanol

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.